Robert Stein, PharmD, JD

Robert L. Stein joined KGI in July 2014. Dr. Stein received his PharmD from the University of Southern California School of Pharmacy, and his JD from Western State University College of Law. Previously, he practiced in a variety of clinical, management, and consulting roles, most recently in clinical Informatics and Information Technology as applied to healthcare. His professional interests focus on developments at the intersections of pharmacy law, ethics, healthcare technology and analytics, and e-discovery of health records. Dr. Stein is actively involved in the national dialog (both clinical and legal) over the role of pharmacists in recommending and monitoring use of medical cannabis.

Dr. Stein is an active member of American Society of Health System Pharmacists (ASHP), California Society of Health System Pharmacists, American Society for Pharmacy Law (ASPL), and the Orange County Bar Association. He was a panelist in Western State University College of Law’s symposium on medical marijuana, presenting a health care professional’s view. He has participated on numerous committees for ASHP and is a past member of the Health Information Management Systems Society’s national Public Policy Committee.

“SNOMED-CT and ICD-10: Capturing Codes for Pharmacy’s Success,” American Society of Health System Pharmacists 2016 Summer Meeting, Baltimore, MD, presented 13 June 2016 (Target audience: general pharmacists and pharmacy informatics professionals)

“Reinforcing Law and Ethics with Active Board of Pharmacy Cases,” American Society for Pharmacy Law 2015 Developments in Pharmacy Law Seminar, Miami, FL, presented 14 November 2015 (Target audience: Pharmacy law instructors, pharmacists, attorneys in pharmacy practice.)

“A Primer on Controlled Substance Law for the Health Care Provider,” Orange County Bar Association, Newport Beach, CA, presented 16 October 2015 (Target audience is attorneys who advise healthcare clients.)

ASHP Statement on the Role of the Medication Safety Leader. Am. J. Health Syst. Pharm., 2013 March; 70:448-552 (Manuscript Reviewer)

ASHP Statement on the Pharmacist’s Role in Medication Reconciliation. Am. J. Health Syst. Pharm., March 2013 70:453-456 (Manuscript Reviewer)

Business Law Panelist, presenting health care professionals’ perspectives on medicinal marijuana in California. Western State Law Review Medical Marijuana Symposium, Fullerton, CA March 23, 2013. Transcript in Western State University Law Review 2013; 41(1): 137

Elements of Successful Technology Contracts (Cover story). Pharmacy Purchasing and Products, 2010 Oct; (7)10:10-12.

“Beyond the Low Hanging Fruit: Automation and Technologies to Optimize Medication Safety”, presented at the Southern California HIMSS 2010 Clinical Informatics Summit, UCLA, 25 June 2010

Microcomputer for controlled substance record keeping. Am. J. Health Syst. Pharm., 1984 Jan; 41(1): 128 – 132

Gentamicin pharmacokinetic predictions (letter). Clin Pharm. 1983 Sep-Oct;2(5):400-1.

Use of inline filters and infusion pumps with TPN solutions (letter). Am. J. Health Syst. Pharm., Dec 1980; 37: 1616 – 1617.